Myomo MYO 深 沪
已收盘 12-12 16:00:00 美东时间
1.05
-0.030
-2.78%
华盛通- 最 高1.09
- 今 开1.08
- 成交量 57.22万股
- 最 低 1.05
- 昨 收 1.08
- 总市值 4035.73万
- 52周最高 7.1699
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.711
- 委 比 -52.94%
- 总股本 3843.55万
- 历史最高 695.88
- 量 比 0.51
- 振 幅 3.70%
- 历史最低 0.369
- 每 手 1
- 风险率 2.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Myomo Affirms FY2025 Sales Guidance of $40.000M-$42.000M vs $40.188M Est
Myomo (AMEX:MYO) affirms FY2025 sales outlook from $40.000 million-$42.000 million to $40.000 million-$42.000 million vs $40.188 million estimate.
11-11 05:08
Myomo Q3 EPS $(0.09), Inline, Sales $10.091M Beat $9.438M Estimate
Myomo (AMEX:MYO) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 200 percent decrease over losses of $(0.03) per share from the same period last year. The company
11-11 05:08
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
A Peek at Myomo's Future Earnings
Myomo (AMEX:MYO) is preparing to release its quarterly earnings on Monday, 2025...
11-08 03:06
Deep Dive Into Supernus Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)
Ratings for Supernus Pharmaceuticals (NASDAQ:SUPN) were provided by 5 analysts ...
10-24 05:02
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
09-23 09:52
Ascendiant Capital Maintains Buy on Myomo, Lowers Price Target to $10.5
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $11.5 to $10.5.
09-22 17:57
“三重利好”点燃特斯拉股价情绪！马斯克押宝Optimus机器人量产，这些概念也要爆？
“三重利好”点燃股价情绪！特斯拉两日飙涨14%，马斯克押宝Optimus机器人量产，这些港美股概念公司有望受益？>>
09-15 17:39
Bitcoin Dips Below $110,000 As Ethereum, XRP, Dogecoin Extend Losses
Cryptocurrency markets are trading slightly down as Bitcoin has dipped below the crucial $110,000 mark.
08-26 20:14
